Stack #5: Semaglutide + AOD-9604 (Appetite control + fat mobilization) Why its popular: People want the GLP-1 appetite effect plus something that targets fat. What semaglutides evidence actually looks like Semaglutide 2.4 mg once weekly has strong RCT evidence for substantial weight loss when paired with lifestyle intervention (e.g., STEP trials)
Rooted in simplicity, it emphasizes nutrient-dense ingredients like lean proteins, healthy fats, fruits, and vegetables while eliminating processed foods, grains, and refined sugars
Additionally, in murine models exposed to dexamethasone, it was observed that the excretion of N-methylhistidinea marker indicative of muscle protein breakdownappeared reduced to a greater extent by IGF-1 LR3, potentially threefold more than by IGF-I
Zepbound (tirzepatide): Approved in 2023 for chronic weight management
At Kinneys, existing pharmacy customers may be enrolled in the bridge program within minutes, Marraffa said